Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / July / 2.2M Grant Backs Retinal Research
Health Economics and Policy Retina News Latest

$2.2M Grant Backs Retinal Research

University of Minnesota researchers receive $2.2M NIH grant to investigate retinal disease treatments

6/22/2026 1 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions
Objective:

A University of Minnesota Medical School research team aims to study the causes of retinal diseases and identify potential new treatments, focusing on age-related macular degeneration (AMD) and Doyne honeycomb retinal dystrophy/Malattia Leventinese.

Approach:
    Key Findings:
    • Fibulin-3 alterations are linked to several blinding eye diseases.
    • AMD is a leading cause of vision loss.
    • Doyne honeycomb retinal dystrophy/Malattia Leventinese is a rare inherited retinal disease.
    Interpretation:

    The research aims to enhance understanding of fibulin-3.

    Conclusion:

    The study is already underway, supported by a four-year, $2.2 million grant from the National Eye Institute.

    Sources:
    • University of Minnesota

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: